XM does not provide services to residents of the United States of America.
V
V

Victrex

News

Elisa Oyj, KBC Groep NV, L'Oreal

EUROPE RESEARCH ROUNDUP-Elisa Oyj, KBC Groep NV, L'Oreal Feb 13 (Reuters) - Securities analysts revised their ratings and price targets on several European companies including Elisa Oyj, KBC Groep NV and L'Oreal, on Tuesday. HIGHLIGHTS * Avanza Bank AVANZ.ST : Citigroup raises to neutral from sell * Elisa Oyj ELISA.HE : HSBC raises to buy from hold * Endomines Finland Oyj PAMPALO.HE : Evli Research cuts to sell from hold * KBC Groep NV KBC.BR : CFRA raises to hold from sell * L'Oréal OREP.PA :
A
A
C
E
E
F
G
G
H
K
L
L
L
R
S
V
V
A
Y

UK stocks fall for second week; Legal & General drags down insurance sector

UPDATE 2-UK stocks fall for second week; Legal & General drags down insurance sector For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window Tesco to sell banking operations to Barclays Legal & General falls as Citigroup cuts target price FTSE 100 down 0.3%, FTSE 250 off 0.2% Updated at 1650 GMT By Khushi Singh and Shubham Batra Feb 9 (Reuters) - UK stocks fell on Friday after a drop in Legal and General Group dragged the life insurance sector l
A
E
L
V
U

UK's Victrex falls on weak earnings outlook

BUZZ-UK's Victrex falls on weak earnings outlook ** Shares in specialty chemicals maker Victrex Plc VCTX.L down 10.4% at 1,152p ** Stock among top pct losers across London stocks, bottoms FTSE mid-cap index .FTMC ** Co expects first-half revenue and profit lower than last year, citing market challenges and reduced asset utilization ** Flags slow st
V

Victrex PLC Says It Had A Soft Start To FY 2024 In Line With Guidance

BRIEF-Victrex PLC Says It Had A Soft Start To FY 2024 In Line With Guidance Feb 9 (Reuters) - Victrex PLC VCTX.L : VICTREX PLC - A SOFT START TO FY 2024 - IN LINE WITH GUIDANCE VICTREX PLC - Q1 GROUP REVENUE DOWN 22% AT £61.2M (Q1 2023: £78.8M) VICTREX PLC - JANUARY TRADING WAS SOLID AND ENDED SLIGHTLY AHEAD OF PRIOR YEAR COMPARATIVE VICTREX PLC
V

Antofagasta, Rational, Spirax-Sarco

EUROPE RESEARCH ROUNDUP-Antofagasta, Rational, Spirax-Sarco Jan 31 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Antofagasta, Rational and Spirax-Sarco, on Wednesday. HIGHLIGHTS * Antofagasta ANTO.L : Citigroup raises target price to 2100p from 1700p * Deutsche Bank AG DBKGn.DE : Citigroup cuts to neutral from buy * Rational AG RAAG.DE : Exane BNP Paribas cuts to underperform from neutral * Spirax-Sarco SPX.L : Jefferies raises t
3
A
A
A
A
A
A
B
C
C
D
D
D
D
D
D
D
E
E
E
G
H
H
H
I
K
L
L
P
P
R
R
S
S
S
S
U
V
W
A
A
B
E
F
S
Z

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.